Streetbeat News

Stock Prices

YMAB

Y-mAbs Therapeutics reported a Q2 2024 GAAP EPS of $(0.21), missing the estimate of $(0.15). Sales were $22.798M, also missing the estimate of $23.019M.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:31 am

TSLA

Elon Musk acknowledged that Tesla's naming conventions for its Full Self-Driving (FSD) software versions are becoming 'a bit silly.' Tesla recently rolled out version 12.5.1.3 of its FSD software, which includes both major upgrades and minor enhancements. Musk also mentioned that Tesla has a 'clear path' to improving FSD performance and plans to release several versions in quick succession. The fully autonomous FSD technology is still pending technological advancements and regulatory approval.

Portfolio Pulse from Anan Ashraf

August 12, 2024 | 10:11 am

SCPH

scPharmaceuticals has announced a proposed underwritten public offering of common stock and pre-funded warrants. The details of the offering have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:10 am

BEKE

KE Holdings has increased its share repurchase authorization from $2 billion to $3 billion and extended the program until August 31, 2025. The board of directors approved these modifications on August 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:07 am

BEKE

KE Holdings (NYSE:BEKE) reported Q2 2024 adjusted earnings per ADS of $0.31, beating the $0.21 estimate. Sales were $3.20 billion, surpassing the $3.09 billion estimate. However, the reported earnings and sales missed the analyst consensus estimates by significant margins.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:05 am

SCPH

scPharmaceuticals announced positive topline results from the pharmacokinetic study of SCP-111, a low volume, pH-neutral formulation of furosemide administered via an autoinjector. SCP-111 demonstrated high bioavailability and similar efficacy to IV furosemide with minimal pain and manageable adverse events.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:04 am

AIMD

LGMK

MMAT

Ainos, Inc. (NASDAQ:AIMD) shares surged 37.7% in pre-market trading after securing exclusive licenses for 10 patents from Taiwan Carbon Nano Technology. Other notable pre-market movers include LogicMark, Inc. (NASDAQ:LGMK) up 49% following a $4.5 million public offering, and Meta Materials Inc. (NASDAQ:MMAT) down 27.7% after filing for Chapter 7 bankruptcy.

Portfolio Pulse from Avi Kapoor

August 12, 2024 | 10:04 am

GOLD

Barrick Gold (NYSE:GOLD) reported Q2 2024 adjusted EPS of $0.32, beating the $0.27 estimate. Sales were $3.162 billion, surpassing the $3.114 billion estimate and marking an 11.61% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:03 am

BNS

KEY

Scotiabank is making a $2.8 billion strategic investment in KeyCorp, acquiring a 14.9% stake at $17.17 per share. This investment will bolster KeyCorp's capital and earnings, increasing its CET1 capital ratio and tangible book value per share. The transaction is expected to be accretive to KeyCorp's earnings in 2025 and 2026. The deal is subject to regulatory approvals and will be completed in two tranches.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:03 am

ESPR

Esperion Therapeutics has reiterated its full-year 2024 operating expense guidance of approximately $225M-$245M, which includes $20M in non-cash expenses related to stock compensation.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:02 am